Report warns about potential impact of missed screenings during Covid

...While it’s good that people are resuming their regular visits, the data suggest people haven’t been making up for the missed screens earlier in the pandemic, said Ahmedin Jemal, senior vice president of surveillance and health equity science at the American Cancer Society and the senior author on the study.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: Why public health officials are not panicked about bird flu

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

China claims its COVID-19 epidemic has 'basically' ended, but not completely over

COVID-19 vaccination may lower risks of heart attack, stroke if infected--study

COVID-19 linked to 40% increase in autoimmune disease risk--study

Masks: Study on masks vs N95 respirators for health workers spurs concerns

Two recent publications conclude there are no differences between surgical masks and respirators for preventing person-to-person transmission of infectious respiratory viruses like SARS-CoV-2 and influenza. But these studies are deeply flawed.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19 Rebound Can Happen Even Without Paxlovid

...

Various studies and anecdotal data have found vastly different rates of rebound among both Paxlovid users and untreated people.arious studies and anecdotal data have found vastly different rates of rebound among both Paxlovid users and untreated people. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Flu vaccine worked well this season--CDC

The new claims that masks are not effective come under scrutiny

COVID pills fail to prevent infection among household members

WHO experts are evaluating new COVID varients to determine need for iupdayed vaccines

Corrected entry: Higher ivermectin dose, longer duration still ineffective for COVID, new trial

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ivermectin: Higher dose, longer duration still ineffective for COVID, new trial finds

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Brain changes detected after COVID-19 infection, even in mild cases --study

...

"Our findings are concerning, as even people with a mild case of COVID-19 are showing changes in their brains months later. More studies are needed to hopefully identify treatments to prevent any long-term effects on people's quality of life," she added.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Liberia RSS
howdy folks